Literature DB >> 15920162

Absence of immunoglobulin class switch in primary lymphomas of the central nervous system.

Manuel Montesinos-Rongen1, Roland Schmitz, Cornelius Courts, Werner Stenzel, Dörte Bechtel, Gerald Niedobitek, Ingmar Blümcke, Guido Reifenberger, Andreas von Deimling, Berit Jungnickel, Otmar D Wiestler, Ralf Küppers, Martina Deckert.   

Abstract

Primary lymphomas of the central nervous system (PCNSLs) were investigated for their capacity to perform further maturation steps. We studied a series of 11 PCNSLs derived from immunocompetent patients for immunoglobulin (Ig) class switch recombination (CSR) by performing reverse transcriptase-polymerase chain reaction (RT-PCR) for transcripts of Ig constant region gene segments (IGHC). This analysis revealed exclusive transcription of IgM and IgD mRNA in the absence of IgG, IgA, or IgE transcription. This finding was corroborated at the protein level by the immunohistochemical demonstration of IgM on the surface of the tumor cells. The unexpected lack of CSR may be due to internal switch mu region deletions, which were detected in 7 of 11 cases. We also found that expression of activation-induced cytidine deaminase (AID), which is required for CSR and somatic hypermutation, was detectable by RT-PCR in 4 of 10 cases and by immunohistochemistry in one of three cases analyzed. This may indicate that ongoing somatic mutation, which is often observed in PCNSL, could be due to sustained AID expression in a fraction of cases and that intraclonal V gene diversity may occur in other cases at an earlier phase of tumor clone expansion, when AID may have been expressed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15920162      PMCID: PMC1602401          DOI: 10.1016/S0002-9440(10)62487-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

1.  Most immunoglobulin heavy chain switch mu rearrangements in B-cell chronic lymphocytic leukemia are internal deletions.

Authors:  Elena Nardini; Simona Rizzi; Daniela Capello; Umberto Vitolo; Gianluca Gaidano; Sylvie Menard; Andrea Balsari
Journal:  FEBS Lett       Date:  2002-05-08       Impact factor: 4.124

Review 2.  IMGT databases, web resources and tools for immunoglobulin and T cell receptor sequence analysis, http://imgt.cines.fr.

Authors:  M-P Lefranc
Journal:  Leukemia       Date:  2003-01       Impact factor: 11.528

3.  Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment.

Authors:  M Montesinos-Rongen; R Küppers; D Schlüter; T Spieker; D Van Roost; C Schaller; G Reifenberger; O D Wiestler; M Deckert-Schlüter
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 4.  Mechanism and control of class-switch recombination.

Authors:  John P Manis; Ming Tian; Frederick W Alt
Journal:  Trends Immunol       Date:  2002-01       Impact factor: 16.687

5.  Interphase cytogenetic analysis of lymphoma-associated chromosomal breakpoints in primary diffuse large B-cell lymphomas of the central nervous system.

Authors:  Manuel Montesinos-Rongen; Reina Zühlke-Jenisch; Stefan Gesk; José Ignacio Martín-Subero; Carlo Schaller; Dirk Van Roost; Otmar D Wiestler; Martina Deckert; Reiner Siebert
Journal:  J Neuropathol Exp Neurol       Date:  2002-10       Impact factor: 3.685

Review 6.  Molecular mechanism of class switch recombination: linkage with somatic hypermutation.

Authors:  Tasuku Honjo; Kazuo Kinoshita; Masamichi Muramatsu
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

7.  Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme.

Authors:  M Muramatsu; K Kinoshita; S Fagarasan; S Yamada; Y Shinkai; T Honjo
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

8.  Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype.

Authors:  Laura A Smit; Richard J Bende; Jan Aten; Jeroen E J Guikema; Wilhelmina M Aarts; Carel J M van Noesel
Journal:  Cancer Res       Date:  2003-07-15       Impact factor: 12.701

9.  Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas.

Authors:  Jobst Greeve; Antje Philipsen; Kristina Krause; Wolfram Klapper; Klaus Heidorn; Brian E Castle; Joe Janda; Kenneth B Marcu; Reza Parwaresch
Journal:  Blood       Date:  2003-01-02       Impact factor: 22.113

Review 10.  Primary central nervous system lymphomas.

Authors:  L M DeAngelis
Journal:  Curr Treat Options Oncol       Date:  2001-08
View more
  12 in total

1.  Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma.

Authors:  Christian Grommes; James L Rubenstein; Lisa M DeAngelis; Andres J M Ferreri; Tracy T Batchelor
Journal:  Neuro Oncol       Date:  2019-02-19       Impact factor: 12.300

2.  The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing.

Authors:  I Vater; M Montesinos-Rongen; M Schlesner; A Haake; F Purschke; R Sprute; N Mettenmeyer; I Nazzal; I Nagel; J Gutwein; J Richter; I Buchhalter; R B Russell; O D Wiestler; R Eils; M Deckert; R Siebert
Journal:  Leukemia       Date:  2014-09-05       Impact factor: 11.528

3.  Random-walk enzymes.

Authors:  Chi H Mak; Phuong Pham; Samir A Afif; Myron F Goodman
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2015-09-17

4.  Random Walk Enzymes: Information Theory, Quantum Isomorphism, and Entropy Dispersion.

Authors:  Chi H Mak; Phuong Pham; Myron F Goodman
Journal:  J Phys Chem A       Date:  2019-03-21       Impact factor: 2.781

Review 5.  Introduction of novel agents in the treatment of primary CNS lymphoma.

Authors:  Christian Grommes; Lakshmi Nayak; Han W Tun; Tracy T Batchelor
Journal:  Neuro Oncol       Date:  2019-02-19       Impact factor: 12.300

6.  Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell.

Authors:  M Montesinos-Rongen; A Brunn; S Bentink; K Basso; W K Lim; W Klapper; C Schaller; G Reifenberger; J Rubenstein; O D Wiestler; R Spang; R Dalla-Favera; R Siebert; M Deckert
Journal:  Leukemia       Date:  2007-11-08       Impact factor: 11.528

Review 7.  Advances in Pathobiology of Primary Central Nervous System Lymphoma.

Authors:  Xue-Liang Yang; Yuan-Bo Liu
Journal:  Chin Med J (Engl)       Date:  2017-08-20       Impact factor: 2.628

8.  Epstein-Barr virus infection of naïve B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology.

Authors:  Emily Heath; Noelia Begue-Pastor; Sridhar Chaganti; Debbie Croom-Carter; Claire Shannon-Lowe; Dieter Kube; Regina Feederle; Henri-Jacques Delecluse; Alan B Rickinson; Andrew I Bell
Journal:  PLoS Pathog       Date:  2012-05-10       Impact factor: 6.823

9.  Clinicopathologic characterization of diffuse-large-B-cell lymphoma with an associated serum monoclonal IgM component.

Authors:  M Christina Cox; Arianna Di Napoli; Stefania Scarpino; Gerardo Salerno; Caterina Tatarelli; Caterina Talerico; Mariangela Lombardi; Bruno Monarca; Sergio Amadori; Luigi Ruco
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

10.  The process of somatic hypermutation increases polyreactivity for central nervous system antigens in primary central nervous system lymphoma.

Authors:  Manuel Montesinos-Rongen; Monica Terrao; Caroline May; Katrin Marcus; Ingmar Blümcke; Martin Hellmich; Ralf Küppers; Anna Brunn; Martina Deckert
Journal:  Haematologica       Date:  2021-03-01       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.